Penserra Capital Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $280K | Hold |
|
|||||
|
2023
Q2 | $71K | Buy |
|
|||||
|
2023
Q1 | $94K | Buy |
|
|||||
|
2022
Q4 | $114K | Buy |
|
|||||
|
2022
Q3 | $155K | Sell |
|
|||||
|
2022
Q2 | $398K | Sell |
|
|||||
|
2022
Q1 | $719K | Sell |
|
|||||
|
2021
Q4 | $1.18M | Buy |
|
|||||
|
2021
Q3 | $1.61M | Buy |
|
|||||
|
2021
Q2 | $1.97M | Buy |
|
|||||
|
2021
Q1 | $1.66M | Buy |
|
|||||
|
2020
Q4 | $425K | Buy |
|
|||||
|
2020
Q3 | $214K | Sell |
|
|||||
|
2020
Q2 | $319K | Buy |
|
|||||
|
2020
Q1 | $336K | Buy |
|
|||||
|
2019
Q4 | $125K | Buy |
|
|||||
|
2019
Q3 | $141K | Buy |
|